Fresenius Medical Care (NYSE:FMS) Coverage Initiated by Analysts at StockNews.com

StockNews.com started coverage on shares of Fresenius Medical Care (NYSE:FMS) in a report released on Thursday. The brokerage issued a strong-buy rating on the stock.

Several other equities analysts have also issued reports on the company. Berenberg Bank started coverage on Fresenius Medical Care in a research note on Wednesday, November 6th. They set a “buy” rating and a $25.60 target price on the stock. Truist Financial boosted their price target on shares of Fresenius Medical Care from $22.00 to $23.00 and gave the stock a “hold” rating in a research note on Monday, October 7th.

Fresenius Medical Care Stock Down 2.0 %

Shares of NYSE FMS opened at $22.02 on Thursday. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42. The business’s 50 day moving average is $20.97 and its two-hundred day moving average is $20.30. Fresenius Medical Care has a 52-week low of $17.93 and a 52-week high of $22.76. The firm has a market cap of $12.92 billion, a price-to-earnings ratio of 18.20, a PEG ratio of 1.01 and a beta of 0.91.

Institutional Investors Weigh In On Fresenius Medical Care

Several institutional investors have recently modified their holdings of FMS. Wulff Hansen & CO. raised its stake in Fresenius Medical Care by 1,809.0% in the second quarter. Wulff Hansen & CO. now owns 343,429 shares of the company’s stock valued at $6,556,000 after buying an additional 325,439 shares in the last quarter. Moran Wealth Management LLC raised its position in shares of Fresenius Medical Care by 47.0% during the 3rd quarter. Moran Wealth Management LLC now owns 233,376 shares of the company’s stock worth $4,971,000 after acquiring an additional 74,621 shares in the last quarter. Quantinno Capital Management LP lifted its stake in Fresenius Medical Care by 78.9% during the third quarter. Quantinno Capital Management LP now owns 110,078 shares of the company’s stock worth $2,345,000 after purchasing an additional 48,554 shares during the last quarter. Triasima Portfolio Management inc. boosted its holdings in Fresenius Medical Care by 27.4% in the second quarter. Triasima Portfolio Management inc. now owns 85,430 shares of the company’s stock valued at $1,631,000 after purchasing an additional 18,360 shares in the last quarter. Finally, Franklin Resources Inc. increased its stake in Fresenius Medical Care by 3.3% in the third quarter. Franklin Resources Inc. now owns 74,640 shares of the company’s stock valued at $1,490,000 after purchasing an additional 2,386 shares during the last quarter. 8.25% of the stock is owned by hedge funds and other institutional investors.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.